{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:10:56Z","timestamp":1790867456210,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR- 61\/4\/2018-BMS"],"award-info":[{"award-number":["ICMR- 61\/4\/2018-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["I-1034"],"award-info":[{"award-number":["I-1034"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cellimm.2024.104910","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:17:56Z","timestamp":1734520676000},"page":"104910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Augmented IFN\u03b3 producing ILC1 and IL 17 producing ILC3 in pemphigus vulgaris: Plausible therapeutic target"],"prefix":"10.1016","volume":"408","author":[{"given":"Vishakha","family":"Hooda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujay","family":"Khandpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2024.104910_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.mayocp.2023.11.006","article-title":"Pemphigus vulgaris","volume":"99","author":"Kianfar","year":"2024","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cellimm.2024.104910_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3892\/etm.2021.10770","article-title":"Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (review)","volume":"22","author":"Costan","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cellimm.2024.104910_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100004","article-title":"Epidemiology of pemphigus","volume":"1","author":"Kridin","year":"2021","journal-title":"JID Innov."},{"key":"10.1016\/j.cellimm.2024.104910_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0378-6323.82396","article-title":"Pemphigus in India","volume":"77","author":"Kanwar","year":"2011","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2019.01.001","article-title":"Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis","volume":"45","author":"Das","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cellimm.2024.104910_bb0035","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11427-021-2187-3","article-title":"Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections","volume":"66","author":"Chi","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.cellimm.2024.104910_bb0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.imbio.2015.06.008","article-title":"Distinctive treg associated CCR4-CCL22 expression profile with altered frequency of Th17\/treg cell in the immunopathogenesis of pemphigus vulgaris","volume":"220","author":"Asothai","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2024.104910_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imm.12814","article-title":"T helper type 1 polarizing \u03b3\u03b4 T cells and scavenger receptors contribute to the pathogenesis of pemphigus vulgaris","volume":"153","author":"Das","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2024.104910_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12026-020-09166-0","article-title":"Distorted frequency of dendritic cells and their associated stimulatory and inhibitory markers augment the pathogenesis of pemphigus vulgaris","volume":"68","author":"Das","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2024.104910_bb0055","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of T(H)1\/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-pemphigus vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.cellimm.2024.104910_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2340\/0001555571269271","article-title":"Increased numbers of mast cells in pemphigus vulgaris skin lesions. A histochemical study","volume":"71","author":"Levi-Schaffer","year":"1991","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2008.03638.x","article-title":"Possible role of natural killer cells in pemphigus vulgaris - preliminary observations","volume":"152","author":"Stern","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0070","first-page":"220","volume":"13","author":"Ameglio","year":"1999","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.cellimm.2024.104910_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106900","article-title":"Distorted frequency and functionality of natural killer cells in pemphigus vulgaris: a potential therapeutic target","author":"Hooda","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellimm.2024.104910_bb0080","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ni.3459","article-title":"The evolution of innate lymphoid cells","volume":"17","author":"Vivier","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0090","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2024.104910_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733324","article-title":"The role of innate lymphoid cells in chronic respiratory diseases","volume":"12","author":"Hsu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MOG.0b013e328365d339","article-title":"Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract","volume":"29","author":"Fuchs","year":"2013","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41419-019-1540-2","article-title":"ILC3 function as a double-edged sword in inflammatory bowel diseases","volume":"10","author":"Zeng","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2024.104910_bb0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOH.0000000000000262","article-title":"Group 3 innate lymphoid cells in tissue damage and graft-versus-host disease pathogenesis","volume":"23","author":"Karrich","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0120","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s10067-022-06315-8","article-title":"Imbalance of Th17, treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis","volume":"41","author":"Wang","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0125","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2024.104910_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109921","article-title":"The dysregulation of circulating innate lymphoid cells is related to autoantibodies in pemphigus vulgaris","volume":"117","author":"Zhu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0135","doi-asserted-by":"crossref","first-page":"1130933","DOI":"10.3389\/fimmu.2023.1130933","article-title":"ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses","volume":"14","author":"Topczewska","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41467-019-13734-w","article-title":"TGF-\u03b2 induces ST2 and programs ILC2 development","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2024.104910_bb0145","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.immuni.2020.09.002","article-title":"In situ maturation and tissue adaptation of type 2 innate lymphoid cell progenitors","volume":"53","author":"Zeis","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2024.104910_bb0150","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0155","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41590-019-0425-y","article-title":"Subsets of ILC3\u2212ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues","volume":"20","author":"Cella","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0160","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.imbio.2015.06.008","article-title":"Distinctive treg associated CCR4-CCL22 expression profile with altered frequency of Th17\/treg cell in the immunopathogenesis of pemphigus vulgaris","volume":"220","author":"Asothai","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2024.104910_bb0165","doi-asserted-by":"crossref","first-page":"7151285","DOI":"10.1155\/2017\/7151285","article-title":"Th1\/Th17-related cytokines and chemokines and their implications in the pathogenesis of pemphigus vulgaris","volume":"2017","author":"Timoteo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cellimm.2024.104910_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155026","article-title":"Pathogenic and protective roles of cytokines in pemphigus: a systematic review","volume":"129","author":"Tavakolpour","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.cellimm.2024.104910_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109921","article-title":"The dysregulation of circulating innate lymphoid cells is related to autoantibodies in pemphigus vulgaris","volume":"117","author":"Zhu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0180","doi-asserted-by":"crossref","first-page":"1915068","DOI":"10.1155\/2021\/1915068","article-title":"Dysregulation of innate lymphoid cells in patients with active rheumatoid arthritis and mice with collagen-induced arthritis","volume":"2021","author":"Yang","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cellimm.2024.104910_bb0185","first-page":"676","article-title":"Innate lymphoid cells are increased in systemic lupus erythematosus","volume":"37","author":"Hou","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","article-title":"Skin-resident innate lymphoid cells converge on a pathogenic effector state","volume":"592","author":"Bielecki","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2024.104910_bb0195","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s10067-022-06315-8","article-title":"Imbalance of Th17, treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis","volume":"41","author":"Wang","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0200","first-page":"676","article-title":"Innate lymphoid cells are increased in systemic lupus erythematosus","volume":"37","author":"Hou","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cellimm.2024.104910_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molimm.2018.11.015","article-title":"A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders","volume":"105","author":"Kamali","year":"2019","journal-title":"Mol. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874924001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874924001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:31:23Z","timestamp":1777390283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874924001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"alternative-id":["S0008874924001138"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2024.104910","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmented IFN\u03b3 producing ILC1 and IL 17 producing ILC3 in pemphigus vulgaris: Plausible therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2024.104910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104910"}}